According to this, the 2016 WHO brain tumor classification classified (anaplastic) astrocytoma based on the existence of IDH mutation, and the diagnosis of (anaplastic) oligodendroglioma requires coexistence of IDH mutation and 1p/19q co-deletion (Preusser and Marosi, 2017). This evidence concerns the gene IDH2 and brain neoplasm.